Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

First Patient Enrolled in NIH Phase 3 Trial to Evaluate Potential COVID-19 Hyperimmune Medicine

americanpharmaceuticalreviewOctober 15, 2020

Tag: COVID-19 , CoVIg-19 Plasma Alliance , NIH

PharmaSources Customer Service